Prostate Cancer
Prostate cancer is a type of cancer that occurs in the prostate, a small gland that produces seminal fluid in men. It can cause symptoms such as difficulty urinating, blood in urine, and pelvic discomfort.
Prostate Cancer: Apalutamide with Radiation Therapy
We are studying whether adding stereotactic body radiation therapy to Apalutamide improves treatment outcomes for men with low burden metastatic hormone-sensitive prostate cancer. This trial compares standard treatment alone to the combination therapy.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have prostate cancer that has spread to 5 or fewer areas outside the prostate?
- Have you had surgery or radiation for prostate cancer in the past?
- Have you started hormone therapy for your prostate cancer in the last 6 months?
- Do you have any health issues that would prevent you from taking Apalutamide?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Sanitaria Locale Cn2 Alba-Bra
SC Oncologia
Alba, Italy
Azienda Sanitaria Usl Toscana Sud Est
UOC Oncologia
Arezzo, Italy
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Dipartimento Malattie Oncologiche ed Ematologiche
Bologna, Italy
Sponsor: Fondazione Radioterapia Oncologica Onlus
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.